ZA200704286B - Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation - Google Patents

Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation

Info

Publication number
ZA200704286B
ZA200704286B ZA200704286A ZA200704286A ZA200704286B ZA 200704286 B ZA200704286 B ZA 200704286B ZA 200704286 A ZA200704286 A ZA 200704286A ZA 200704286 A ZA200704286 A ZA 200704286A ZA 200704286 B ZA200704286 B ZA 200704286B
Authority
ZA
South Africa
Prior art keywords
preparation
phytosterol
diglyceride
delivery
metal cations
Prior art date
Application number
ZA200704286A
Other languages
English (en)
Inventor
Maurel Jean-Claude
Original Assignee
Medesis Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medesis Pharma filed Critical Medesis Pharma
Publication of ZA200704286B publication Critical patent/ZA200704286B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Psychology (AREA)
ZA200704286A 2004-11-02 2007-05-25 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation ZA200704286B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04025987A EP1652512A1 (de) 2004-11-02 2004-11-02 Umkehrmizellen-Zusammensetzung zur Verabreichung von Metallkationen enthaltend einen Diglycerid und einen Phytosterol und Verfahren zur Herstellung

Publications (1)

Publication Number Publication Date
ZA200704286B true ZA200704286B (en) 2008-09-25

Family

ID=34927200

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704286A ZA200704286B (en) 2004-11-02 2007-05-25 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation

Country Status (17)

Country Link
US (1) US9173838B2 (de)
EP (2) EP1652512A1 (de)
JP (1) JP4975631B2 (de)
CN (1) CN101102751B (de)
AT (1) ATE483454T1 (de)
AU (1) AU2005300253B2 (de)
CA (1) CA2584684C (de)
DE (1) DE602005024036D1 (de)
DK (1) DK1807048T3 (de)
EA (1) EA012210B1 (de)
ES (1) ES2353804T3 (de)
HK (1) HK1108368A1 (de)
IL (1) IL182756A (de)
PL (1) PL1807048T3 (de)
PT (1) PT1807048E (de)
WO (1) WO2006048773A1 (de)
ZA (1) ZA200704286B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1652513A1 (de) * 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse Mizellen auf der Basis von Sterolen und Acylglycerolen und ihre therapeutischen Verwendungen
US9592218B2 (en) 2010-03-24 2017-03-14 Medesis Pharma Reverse micelle system comprising metal ions and use thereof
BRPI1000970A2 (pt) * 2010-04-07 2011-11-29 Fundacao Arnaldo Vieira De Carvalho composição farmacêutica para o tratamento da doença de alzheimer, processo para sua obtenção e uso
WO2012007387A1 (en) * 2010-07-13 2012-01-19 Medesis Pharma Low- dose lithium for the treatment of neurodegenerative disorders
CN108323159A (zh) * 2015-07-09 2018-07-24 麦迪西斯医药公司 在生物相容性反胶束系统内原位制备氰基桥接的金属纳米粒子
CN112672735A (zh) * 2018-07-06 2021-04-16 麦迪西斯医药公司 对由辐射暴露引起的损伤的治疗和预防
WO2024184369A1 (en) * 2023-03-06 2024-09-12 Medesis Pharma Formulation for the buccal administration of a biocompatible reverse micelle system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252333A (en) * 1987-04-27 1993-10-12 Scotia Holdings Plc Lithium salt-containing pharmaceutical compositions
FR2658816A1 (fr) * 1990-02-27 1991-08-30 Adir Nouveaux sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2729957B1 (fr) 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
FR2750606B1 (fr) * 1996-07-03 1999-01-29 Maurel Sante Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant
JPH119988A (ja) * 1997-06-26 1999-01-19 Advanced Sukin Res Kenkyusho:Kk 油中水型マイクロエマルション
JPH1129464A (ja) * 1997-07-07 1999-02-02 Advanced Sukin Res Kenkyusho:Kk コレステロールを添加する油中水型マイクロエマルション
AU4031500A (en) * 1999-03-26 2000-10-16 Akesis Pharmaceuticals, Inc. Edible solids for treatment of glucose metabolism disorders
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
US6365176B1 (en) * 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
PL201177B1 (pl) * 2001-01-25 2009-03-31 Unilever Nv Jadalna mikroemulsja woda w oleju, sposób jej wytwarzania oraz jej zastosowanie
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
EP1452175A1 (de) * 2003-02-28 2004-09-01 Medesis Pharma S.A. Organometallische Komplexe entahltend Mangan, pharmazeutische Formulierungen und Diätetika
CN1457773A (zh) * 2003-06-02 2003-11-26 乐益 治疗糖尿病的双胍钒络合物颗粒剂和/或胶囊剂及其用途
EP1652513A1 (de) * 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse Mizellen auf der Basis von Sterolen und Acylglycerolen und ihre therapeutischen Verwendungen

Also Published As

Publication number Publication date
EP1652512A1 (de) 2006-05-03
IL182756A0 (en) 2007-07-24
EA012210B1 (ru) 2009-08-28
JP2008519026A (ja) 2008-06-05
HK1108368A1 (en) 2008-05-09
EP1807048B1 (de) 2010-10-06
EP1807048A1 (de) 2007-07-18
JP4975631B2 (ja) 2012-07-11
CA2584684A1 (en) 2006-05-11
ES2353804T3 (es) 2011-03-07
US20090087477A1 (en) 2009-04-02
AU2005300253B2 (en) 2010-09-09
WO2006048773A1 (en) 2006-05-11
DK1807048T3 (da) 2011-01-10
CA2584684C (en) 2013-07-02
DE602005024036D1 (de) 2010-11-18
CN101102751B (zh) 2011-08-24
IL182756A (en) 2011-02-28
CN101102751A (zh) 2008-01-09
PT1807048E (pt) 2010-11-29
PL1807048T3 (pl) 2011-03-31
ATE483454T1 (de) 2010-10-15
US9173838B2 (en) 2015-11-03
EA200700994A1 (ru) 2007-10-26
AU2005300253A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
HK1108368A1 (en) Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
WO2007110421A3 (en) Whey protein micelles
EP2462924A3 (de) Verbesserungen an oder im Zusammenhang mit amphoteren Liposomen
EP2695608A3 (de) Lipidhaltige Formulierungen
WO2005067898A3 (en) Improved sustained release compositions for pulmonary administration of insulin
MX2010006199A (es) Composicion nutricional enterica liquida basada en caseina micelar, densa en cuanto a proteina.
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
IL178128A0 (en) Salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same
IL190646A (en) Multifunctional June Liquid Preparations, Including Pharmaceutical, Bioactive, Nutritional and Energetic Vehicles and Method for Preparing
IL198612A (en) @Human ligand @ ligand @@@ human delta-like method, method of making them, preparations containing them and using them @ making @ drugs
EP1698329A4 (de) Arzneihaltiges nanoteilchen, verfahren zu seiner herstellung und parenteral verabreichtes präparat aus dem nanoteilchen
CA2595907A1 (en) Creatine hydroxycitric acid salts and methods for their production and use in individuals
IL165609A (en) A vii polypeptide factor conjugate, a method for its preparation, and a pharmaceutical composition containing it
EP2045900A3 (de) Flussschaltmaschine
WO2005079396A3 (en) O,o'-amidomalonate and n,o-amidomalonate platinum complexes
EP1806149A4 (de) Feste medizinische zubereitung mit verbesserter löslichkeit und stabilität und verfahren zu ihrer herstellung
WO2009050580A8 (fr) Composition destinee a la regulation du metabolism des lipides
FR2934955B1 (fr) Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
TW200603746A (en) Iron sulfate based phosphate adsorbent
WO2007064968A3 (en) Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate
ZA200704246B (en) Solid medicinal preparation improved in solubility and stability and process for producing the same
EP1637167A3 (de) Neue einspritzbare Formulierungen enthaltend Progesteron
WO2008063808A3 (en) Encapsulated peptide amphiphile nanostructures
WO2008011272A3 (en) Liquid monophasic lipid-soluble antioxidant compositions and processes for making the compositions
SI1742927T1 (sl) Derivati butanojske kisline, postopki za pripravo le-teh, farmacevtski sestavki, ki jih vsebujejo in terapevtske uporabe le-teh